Practice Management News

KOLOA, Hawaii — After 25 years of attending and presenting at Hawaiian Eye, renowned speaker Alan E. Reider, JD, MPH, announced his retirement here at the conclusion of his Hawaiian Eye 2017 presentation on compliance.

The members of the House of Representatives approved a budget resolution Friday by a vote of 227-198. The budget resolution approval was the first step for the Republicans to repeal the Affordable Care Act.

With 8 days until President-elect Donald J. Trump is inaugurated, his approach to health care policy appears to be in conflict with the goals of the ACP.

The members of the U.S. Senate took the first step Thursday morning to repeal the Affordable Care Act by approving a budget blueprint by a vote of 51-48.

As of December 24, 2016, more than 11.5 million people in the United States, including 8.9 million returning consumers and 2.6 million new consumers, had signed up for Health Insurance Marketplace coverage, surpassing last year by 286,000 plans, according to a new report issued by the HHS. This increased utilization of the Marketplace established by the Affordable Care Act (ACA) was announced the same day President-elect Donald J. Trump reaffirmed that he will repeal and replace the ACA at a press conference.

Calling it a “complete and total disaster,” President-elect Donald J. Trump today reaffirmed he will repeal and replace the Affordable Care Act.

In her last public speech on the Affordable Care Act, outgoing HHS Secretary Sylvia Mathews Burwell touted progress made under the legislation, but warned of what could happen if Republicans succeed in repealing it.

A recent letter published in JAMA Internal Medicine reports two of nine human immune globulin products tested for hepatitis A prophylaxis efficacy just meet the minimal potency level required by the European Pharmacopeia.

As inauguration day for President-elect Donald J. Trump looms, the future status of the Affordable Care Act remains uncertain. The ACP and several specialists offer insight on what would happen to the nation’s health care if the Trump administration’s plan to repeal and replace the current law is carried out.

Recent changes in metformin labeling by the FDA is supported by new findings published in Annals of Internal Medicine that suggest that patients with chronic kidney disease, congestive heart failure and chronic liver disease receiving the drug experienced improvements in all-cause mortality.